Sequani Limited

Sequani Limited is a specialized provider of non-clinical support services for drug development, crop protection, and chemical safety, ensuring compliance with regulatory standards and delivering scientific expertise. Founded in 1971, Sequani Limited specializes in non-clinical support services related to drug development and agricultural chemicals. The company is headquartered in Ledbury, England, and has established a strong presence in Europe and North America. Stephen Eckley currently serves as CEO, steering the company's strategic direction towards innovative solutions in safety and efficacy assessments.

Sequani Limited specializes in providing comprehensive non-clinical support services in the fields of drug development, crop protection, and chemical safety. Their core offerings include lead optimization, toxicology assessments, pharmacokinetics, and formulation development, which are critical throughout the various phases of drug development, from initial testing through to Phase III trials. They also deliver scientific expertise for the safety evaluation of agricultural chemicals, ensuring compliance with regulatory standards for crop protection technologies. Their clientele comprises pharmaceutical companies, agricultural firms, and chemical manufacturers primarily based in Europe and North America, focusing on delivering solutions that address the rigorous demands of safety and efficacy in product development.

Sequani Limited's revenue generation is structured around business-to-business transactions, primarily through contracts with pharmaceutical and agricultural companies seeking non-clinical support services. Transactions typically involve project-based agreements where clients engage Sequani for specific studies or assessments, often structured as retainer contracts for ongoing support. The pricing framework is customized based on the complexity and scope of services, which can include multi-phased studies in drug development and comprehensive safety evaluations in chemical registration. As a result, Sequani's flagship services facilitate a steady revenue stream from both established clients and new partnerships within the pharmaceutical and agricultural sectors.